FreshRecalls

⚠ Data freshness notice: the most recent refresh of NHTSA was incomplete, so a very recent recall may be missing. Everything shown is accurate as of the last checked time on this page — for anything time-critical, confirm with the official sources linked below.

FDAClass II · Drug · Recalled July 15, 2026

Methohexital Sodium for Injection recall — ONESOURCE SPECIALTY PHARMA LIMITED

Hazard: Failed Impurities/Degradation Specifications

Class II: may cause temporary or medically reversible health consequences.

View the official FDA enforcement record (openFDA) ↗

Official recall ID
D-0662-2026
Brand
ONESOURCE SPECIALTY PHARMA
Classification
Class II
Units affected
4284 vials
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Description

Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31

Affected products

Companies & origin

Recalling firm location
Bengaluru, N/A, India
Firm address
Plot No.: 2-D1, Obadenahalli Industrial Area, Doddaballapura, 3rd Phase; Kasa, Doddaballapura Taluk, N/A

Identifying details (verbatim from the notice)

Product codes / lots
Lot #: 7000612A, Exp. Date 1/2028
Distribution
Nationwide within the United States
Firm notified the public via
Letter
FDA event ID
99220
Recall initiated
June 7, 2026
FDA classified
July 7, 2026
FDA report date
July 15, 2026

Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim; the linked government source is authoritative. Source last checked July 23, 2026 at 11:04 PM UTC.

Report a data error on this page